Application Deadline: 27 July 2021
With the support of the German Federal Ministry of Education and Research (BMBF), TWAS launches a new programme to strengthen the capacity of African countries lagging in science and technology. The new programme is aimed at young scientists who are getting established in their country or about to return home to an academic position. Under this scheme, grants are awarded to promising high-level research projects in Agriculture, Biology, Chemistry, Earth Sciences, Engineering, Information Computer Technology, Mathematics, Medical Sciences and Physics carried out in African countries lagging in science and technology identified by TWAS.
The
Seed Grant for New African Principal Investigators (SG-NAPI) was established in response to the needs of researchers in developing countries, particularly those attached to institutions that lack appropriate research facilities. Under this scheme, grants can be awarded for research projects in Agriculture, Bi
Bharat Biotech Covaxin shows 78 percent overall interim efficacy, 100 percent efficacy against severe Covid medicaldialogues.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicaldialogues.in Daily Mail and Mail on Sunday newspapers.
Apr 21, 2021
Safety and Efficacy results from the final analysis will be available in June, and the final report will be submitted to a peer-reviewed publication. Based on the achievement of the success criteria, placebo recipients have now become eligible to receive two doses of COVAXIN®.
The Phase 3 study enrolled 25,800 participants between 18-98 years of age, including 10% over the age of 60, with analysis conducted 14 days post 2
nd dose. COVAXIN® was developed with seed strains received from the National Institute of Virology, and the phase 3 clinical trial was co-funded by the Indian Council of Medical Research, making it a true public, private partnership towards public health.